Haoxi Health Technology Limited (HAO)
NASDAQ: HAO · Real-Time Price · USD
1.060
-0.050 (-4.50%)
Apr 28, 2026, 4:00 PM EDT - Market closed

Haoxi Health Technology Ratios and Metrics

Millions USD. Fiscal year is Jul - Jun.
Fiscal Year
CurrentFY 2025 FY 2024 FY 2023 FY 2022 FY 2021
Period Ending
Apr '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Market Capitalization
634172---
Market Cap Growth
1494.66%-97.87%----
Enterprise Value
61-4172---
Last Close Price
1.121.30133.50---
PE Ratio
-0.95133.29---
PS Ratio
1.560.113.55---
PB Ratio
4.170.2115.27---
P/TBV Ratio
4.360.2415.27---
EV/Sales Ratio
1.44-3.54---
EV/EBITDA Ratio
--99.29---
EV/EBIT Ratio
--99.90---
Debt / Equity Ratio
0.100.120.110.61-0.34-0.17
Debt / EBITDA Ratio
--0.700.681.380.85
Debt / FCF Ratio
-----0.13
Net Debt / Equity Ratio
-0.33-0.38-0.48-0.16-0.06-0.08
Net Debt / EBITDA Ratio
0.743.87-3.16-0.210.350.47
Net Debt / FCF Ratio
1.551.976.790.28-0.140.06
Asset Turnover
2.001.774.8611.289.63-
Inventory Turnover
6.235.8612.0821.4961.73-
Quick Ratio
0.762.401.840.490.210.18
Current Ratio
3.455.053.981.430.220.56
Return on Equity (ROE)
-15.98%27.06%20.12%1923.73%--
Return on Assets (ROA)
-22.09%-6.74%10.75%29.85%10.01%-
Return on Invested Capital (ROIC)
-70.23%-22.53%35.85%---
Return on Capital Employed (ROCE)
-46.50%-11.30%14.80%63.30%-18.30%-17.70%
Earnings Yield
-4.16%105.66%0.75%---
FCF Yield
-5.06%-91.52%-0.47%---
Buyback Yield / Dilution
-577.16%-95.84%-10.82%-10.45%--
Source: S&P Capital IQ. Standard template. Financial Sources.